Vesilut (20mg)

Vesilut, also known as ED or Glu-Asp, is a synthetic bioregulator peptide from the Khavinson group. Although there is limited research on Vesilut specifically, its Glu-Asp sequence is shared with other bioregulators, and it is being researched for its potential to affect tissues such as the prostate gland and bladder. As a bioregulator, it is hypothesized to act by influencing gene expression on a cellular level.

Product Information

Pricing

Chemical Makeup

Research and Clinical Studies

Urinary Bladder & Prostate Gland Function

Research on related bioregulators suggests that Vesilut's mechanism may be similar, centering on modulating chronic inflammation in tissues surrounding the bladder, such as the prostate gland. Studies on these related peptides have shown a reduction in tissue swelling and hyperemia, which is an excess of blood in the vessels. They also appear to modulate cellular infiltration and may block the development of sclerotic processes, which involve the hardening and stiffening of tissues that could impede bladder function (1).

Gene Bioregulation & Cellular Aging

The potential actions of Vesilut are hypothesized to be related to its influence on gene expression. Peptides with the Glu-Asp sequence are being researched for their potential to interact with chromosomes and chromatin, possibly leading to the decondensation of chromatin (2). This decondensation may reactivate genes that have been silenced over time due to cellular aging.

Furthermore, these related bioregulators are being investigated for their potential to increase the frequency of sister chromatid exchanges (SCE), which may enhance chromosomal repair. They may also impact the activity of ribosomal RNA (rRNA) genes, potentially leading to higher protein synthesis in aging cells (3).

Disclaimer: Vesilut peptide is available for research and laboratory purposes only.